Literature DB >> 23592550

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.

Amin R Mazloom1, Željko Džakula, Paul Oeth, Huiquan Wang, Taylor Jensen, John Tynan, Ron McCullough, Juan-Sebastian Saldivar, Mathias Ehrich, Dirk van den Boom, Allan T Bombard, Margo Maeder, Graham McLennan, Wendy Meschino, Glenn E Palomaki, Jacob A Canick, Cosmin Deciu.   

Abstract

OBJECTIVE: Whole-genome sequencing of circulating cell free (ccf) DNA from maternal plasma has enabled noninvasive prenatal testing for common autosomal aneuploidies. The purpose of this study was to extend the detection to include common sex chromosome aneuploidies (SCAs): [47,XXX], [45,X], [47,XXY], and [47,XYY] syndromes.
METHOD: Massively parallel sequencing was performed on ccf DNA isolated from the plasma of 1564 pregnant women with known fetal karyotype. A classification algorithm for SCA detection was constructed and trained on this cohort. Another study of 411 maternal samples from women with blinded-to-laboratory fetal karyotypes was then performed to determine the accuracy of the classification algorithm.
RESULTS: In the training cohort, the new algorithm had a detection rate (DR) of 100% (95%CI: 82.3%, 100%), a false positive rate (FPR) of 0.1% (95%CI: 0%, 0.3%), and nonreportable rate of 6% (95%CI: 4.9%, 7.4%) for SCA determination. The blinded validation yielded similar results: DR of 96.2% (95%CI: 78.4%, 99.8%), FPR of 0.3% (95%CI: 0%, 1.8%), and nonreportable rate of 5% (95%CI: 3.2%, 7.7%) for SCA determination
CONCLUSION: Noninvasive prenatal identification of the most common sex chromosome aneuploidies is possible using ccf DNA and massively parallel sequencing with a high DR and a low FPR.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592550     DOI: 10.1002/pd.4127

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  42 in total

1.  Genomic testing reaches into the womb.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2013-07       Impact factor: 54.908

2.  Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound.

Authors:  J I Iruretagoyena; M Grady; D Shah
Journal:  J Perinatol       Date:  2015-03       Impact factor: 2.521

3.  Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.

Authors:  Stephanie C Y Yu; K C Allen Chan; Yama W L Zheng; Peiyong Jiang; Gary J W Liao; Hao Sun; Ranjit Akolekar; Tak Y Leung; Attie T J I Go; John M G van Vugt; Ryoko Minekawa; Cees B M Oudejans; Kypros H Nicolaides; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 4.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

Review 5.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

Review 6.  Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.

Authors:  Kathryn J Gray; Louise E Wilkins-Haug
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 7.  Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.

Authors:  Matthew R Grace; Emily Hardisty; Sarah K Dotters-Katz; Neeta L Vora; Jeffrey A Kuller
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

8.  SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy.

Authors:  Carole Samango-Sprouse; Milena Banjevic; Allison Ryan; Styrmir Sigurjonsson; Bernhard Zimmermann; Matthew Hill; Megan P Hall; Margaret Westemeyer; Jennifer Saucier; Zachary Demko; Matthew Rabinowitz
Journal:  Prenat Diagn       Date:  2013-06-20       Impact factor: 3.050

9.  Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.

Authors:  Mathias Ehrich; John Tynan; Amin Mazloom; Eyad Almasri; Ron McCullough; Theresa Boomer; Daniel Grosu; Jason Chibuk
Journal:  Genet Med       Date:  2017-06-15       Impact factor: 8.822

Review 10.  Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA.

Authors:  Lyn S Chitty; Y M Dennis Lo
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.